Concepedia

Júlia Corominas

JC

Statistics

Publications

4

Citations

78

H-Index

4

Active since

2022

Affiliations

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol(Current)

Universitat Autònoma de Barcelona

Universitat de Vic - Universitat Central de Catalunya

IrsiCaixa

Instituto de Salud Carlos III

Júlia Corominas is an author at Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol specializing in clinical trials, precision vaccinology, and immunodeficiencies.

ORCID

Top concepts

Publications per year

2022–2023

4

Publications

4

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Júlia Corominas, Carme Garriga, Antoni Prenafeta et al. · The Lancet Regional Health - Europe · 2023 · 31 citations · Full text

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

Antonio Barreiro, Antoni Prenafeta, G. Bech-Sàbat et al. · iScience · 2023 · 27 citations · Full text

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Júlia Corominas, Carme Garriga, Antoni Prenafeta et al. · 2022 · 10 citations · Full text

, , +20

Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2

Lorna Leal, Judit Pich, Laura Ferrer et al. · npj Vaccines · 2023 · 10 citations · Full text

1–4 of 4